Contrasting roles for Vα14+ natural killer T cells in a viral model for multiple sclerosis

Journal of NeuroVirology

Volumn 15, Issue 1, 2009, Pages 90-98

  Tsunoda, Ikuo ^a   Tanaka, Tomoko ^a   Taniguchi, Masaru ^b   Fujinami, Robert S ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b Institute of Physical and Chemical Research   (Japan)

Author keywords

CD1d; CNS autoimmune demyelinating diseases; Cytokines; INKT lymphocytes; Picornaviridae infections; Theiler's virus

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4; RECEPTOR ANTIBODY; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR VALPHA14; T LYMPHOCYTE RECEPTOR VALPHA14 ANTIBODY; UNCLASSIFIED DRUG; ANTIBODY; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CELL COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DEMYELINATION; DISEASE MODEL; DRUG EFFICACY; FEMALE; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MOUSE; MULTIPLE SCLEROSIS; MURINE ENCEPHALOMYELITIS VIRUS; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; T CELL DEPLETION; TREATMENT DURATION; TREATMENT RESPONSE; ANIMAL; CARDIOVIRUS INFECTION; DRUG ANTAGONISM; IMMUNOLOGY; LEUKAPHERESIS; MOUSE STRAIN; TIME; VIROLOGY;

ANIMALIA; MUS; PICORNAVIRIDAE; THEILER'S ENCEPHALOMYELITIS VIRUS;

ANIMALS; ANTIBODIES; CARDIOVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; LEUKOCYTE REDUCTION PROCEDURES; MICE; MICE, INBRED STRAINS; MULTIPLE SCLEROSIS; NATURAL KILLER T-CELLS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; THEILOVIRUS; TIME FACTORS;

EID: 61849121271     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/13550280802400684     Document Type: Article

References (62)

1. 2; 2-microglobulin-dependent and independent forms. J Immunol, 161, pp. 1710-1717.
2. Apostolou, I., Takahama, Y., Belmant, C., Kawano, T., Huerre, M., Marchal, G., Cui, J., Taniguchi, M., Nakauchi, H., Fournié, J-J, Kourilsky, P. and Gachelin, G. (1999) Murine natural killer T(NKT) cells [correction of natural killer cells] contribute to the granulomatous reaction caused by mycobacterial cell walls. Proc Natl Acad Sci U S A, 96, pp. 5141-5146.
3. 2 bias of CD4+ NKT cells derived from multiple sclerosis in remission. Int Immunol, 15, pp. 279-288.
4. Bannai, M., Oya, H., Kawamura, T., Naito, T., Shimizu, T., Kawamura, H., Miyaji, C., Watanabe, H., Hatakeyama, K. and Abo, T. (2000) Disparate effect of beige mutation on cytotoxic function between natural killer and natural killer T cells. Immunology, 100, pp. 165-169.
5. Baron, JL, Gardiner, L., Nishimura, S., Shinkai, K., Locksley, R. and Ganem, D. (2002) Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection. Immunity, 16, pp. 583-594.
6. Berzofsky, JA and Terabe, M. (2008) NKT cells in tumor immunity: Opposing subsets define a new immunoregulatory axis. J Immunol, 180, pp. 3627-3635.
7. + NK T lymphocytes. J Immunol, 161, pp. 3271-3281.
8. Byrne, P., McGuirk, P., Todryk, S. and Mills, KHG (2004) Depletion of NK cells results in disseminating lethal infection with Bordetella pertussis associated with a reduction of antigen-specific Th1 and enhancement of Th2, but not Tr1 cells. Eur J Immunol, 34, pp. 2579-2588.
9. Cavarra, E., Martorana, PA, de Santi, M., Bartalesi, B., Cortese, S., Gambelli, F. and Lungarella, G. (1999) Neutrophil influx into the lungs of beige mice is followed by elastolytic damage and emphysema. Am J Respir Cell Mol Biol, 20, pp. 264-269.
10. Chiba, A., Kaieda, S., Oki, S., Yamamura, T. and Miyake, S. (2005) The involvement of Vα14 natural killer T cells in the pathogenesis of arthritis in murine models. Arthritis Rheum, 52, pp. 1941-1948.
11. Chiba, A., Oki, S., Miyamoto, K., Hashimoto, H., Yamamura, T. and Miyake, S. (2004) Suppression of collagen-induced arthritis by natural killer T cell activation with OCH, a sphingosine-truncated analog of α-galactosylceramide. Arthritis Rheum, 50, pp. 305-313.
12. Cui, J., Shin, T., Kawano, T., Sato, H., Kondo, E., Toura, I., Kaneko, Y., Koseki, H., Kanno, M. and Taniguchi, M. (1997) Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science, 278, pp. 1623-1626.
13. + αβ T cells in the periimplantation uterus. Immunology, 101, pp. 484-491.
14. Exley, MA, Bigley, NJ, Cheng, O., Tahir, SMA, Smiley, ST, Carter, QL, Stills, HF, Grusby, MJ, Koezuka, Y., Taniguchi, M. and Balk, SP. (2001) CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus. J Leukoc Biol, 69, pp. 713-718.
15. Furlan, R., Bergami, A., Cantarella, D., Brambilla, E., Taniguchi, M., Dellabona, P., Casorati, G. and Martino, G. (2003) Activation of invariant NKT cells by αGalCer administration protects mice from MOG35-55-induced EAE: Critical roles for administration route and IFN-γ. Eur J Immunol, 33, pp. 1830-1838.
16. - Vα24JαQ T cells in peripheral blood of patients with relapsing-remitting multiple sclerosis. Clin Immunol, 98, pp. 11-17.
17. Greenlee, JE and Rose, JW (2000) Controversies in neurological infectious diseases. Semin Neurol, 20, pp. 375-386.
18. Grubor-Bauk, B., Simmons, A., Mayrhofer, G. and Speck, PG (2003) Impaired clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant Vα14-Jα281 TCR. J Immunol, 170, pp. 1430-1434.
19. +NKT cells are resistant to experimental hepatitis but are partially susceptible to generalised Shwartzman reaction. Clin Exp Med, 7, pp. 30-38.
20. Huber, S., Sartini, D. and Exley, M. (2003) Role of CD1d in coxsackievirus B3-induced myocarditis. J Immunol, 170, pp. 3147-3153.
21. Illés, Z., Kondo, T., Newcombe, J., Oka, N., Tabira, T. and Yamamura, T. (2000) Differential expression of NK T cell Vα24JαQ invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy. J Immunol, 164, pp. 4375-4381.
22. α14 cross-reacts with human CD3ε and detects disulfide-linked dimeric form. Int Immunol, 3, pp. 991-995.
23. Jahng, AW, Maricic, I., Pedersen, B., Burdin, N., Naidenko, O., Kronenberg, M., Koezuka, Y. and Kumar, V. (2001) Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis. J Exp Med, 194, pp. 1789-1799.
24. Kaminsky, SG, Nakamura, I. and Cudkowicz, G. (1983) Selective defect of natural killer and killer cell activity against lymphomas in SJL mice: Low responsiveness to interferon inducers. J Immunol, 130, pp. 1980-1984.
25. Kaminsky, SG, Nakamura, I. and Cudkowicz, G. (1985) Genetic control of the natural killer cell activity in SJL and other strains of mice. J Immunol, 135, pp. 665-671.
26. α14 NKT cells by glycosylceramides. Science, 278, pp. 1626-1629.
27. Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Sato, H., Kondo, E., Harada, M., Koseki, H., Nakayama, T., Tanaka, Y. and Taniguchi, M. (1998) Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Vα14 NKT cells. Proc Natl Acad Sci U S A, 95, pp. 5690-5693.
28. Kim, BS, Fuller, AC and Koh, C-S (2005) Cytokines, chemokines and adhesion molecules in TMEV-IDD. Experimental models of multiple sclerosis, pp. 659-671. Springer Science + Business Media, New York
29. Levy, O., Orange, JS, Hibberd, P., Steinberg, S., LaRussa, P., Weinberg, A., Wilson, SB, Shaulov, A., Fleisher, G., Geha, RS, Bonilla, FA and Exley, M. (2003) Disseminated varicella infection due to the vaccine strain of varicella-zoster virus, in a patient with a novel deficiency in natural killer T cells. J Infect Dis, 188, pp. 948-953.
30. + T cell populations. Int Immunol, 7, pp. 1157-1161.
31. Mars, LT, Laloux, V., Goude, K., Desbois, S., Saoudi, A., Van Kaer, L., Lassmann, H., Herbelin, A., Lehuen, A. and Liblau, RS (2002) Vα14-Jα281 NKT cells naturally regulate experimental autoimmune encephalomyelitis in nonobese diabetic mice. J Immunol, 168, pp. 6007-6011.
32. McCright, IJ, Tsunoda, I., Whitby, FG and Fujinami, RS (1999) Theiler's viruses with mutations in loop I of VP1 lead to altered tropism and pathogenesis. J Virol, 73, pp. 2814-2824.
33. + NK T cells associated with disease development in autoimmune-prone mice. J Immunol, 156, pp. 4035-4040.
34. Miyake, S. and Yamamura, T. (2005) Therapeutic potential of glycolipid ligands for natural killer (NK) T cells in the suppression of autoimmune diseases. Curr Drug Targets- Immune Endocr Metab Disord, 5, pp. 315-322.
35. Miyamoto, K., Miyake, S. and Yamamura, T. (2001) A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature, 413, pp. 531-534.
36. Nakagawa, R., Nagafune, I., Tazunoki, Y., Ehara, H., Tomura, H., Iijima, R., Motoki, K., Kamishohara, M. and Seki, S. (2001) Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by α-galactosylceramide in mice. J Immunol, 166, pp. 6578-6584.
37. Paya, CV, Patick, AK, Leibson, PJ and Rodriguez, M. (1989) Role of natural killer cells as immune effectors in encephalitis and demyelination induced by Theiler's virus. J Immunol, 143, pp. 95-102.
38. Pirko, I., Lucchinetti, CF, Sriram, S. and Bakshi, R. (2007) Gray matter involvement in multiple sclerosis. Neurology, 68, pp. 634-642.
39. Potvin, DM, Metzger, DW, Lee, WT, Collins, DN and Ramsingh, AI (2003) Exogenous interleukin-12 protects against lethal infection with coxsackievirus B4. J Virol, 77, pp. 8272-8279.
40. Rigaud, S., Fondanèche, M-C, Lambert, N., Pasquier, B., Mateo, V., Soulas, P., Galicier, L., Le Deist, F, Rieux-Laucat, F., Revy, P., Fischer, A., de Saint Basile, G and Latour, S. (2006) XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature, 444, pp. 110-114.
41. Rose, JW, Watt, HE, White, AT and Carlson, NG (2004) Treatment of multiple sclerosis with an anti-interleukin-2 receptor monoclonal antibody. Ann Neurol, 56, pp. 864-867.
42. Schofield, L., McConville, MJ, Hansen, D., Campbell, AS, Fraser-Reid, B., Grusby, MJ and Tachado, SD (1999) CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science, 283, pp. 225-229.
43. - strains. Exp Anim, 49, pp. 171-180.
44. Sharif, S., Arreaza, GA, Zucker, P., Mi, Q-S and Delovitch, TL (2002) Regulation of autoimmune disease by natural killer T cells. J Mol Med, 80, pp. 290-300.
45. Singh, AK, Wilson, MT, Hong, S., Olivares-Villagómez, D., Du, C., Stanic, AK, Joyce, S., Sriram, S., Koezuka, Y. and Van Kaer, L. (2001) Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J Exp Med, 194, pp. 1801-1811.
46. Singh, AK, Yang, J-Q, Parekh, VV, Wei, J., Wang, C-R, Joyce, S., Singh, RR and Van Kaer, L. (2005) The natural killer T cell ligand α-galactosylceramide prevents or promotes pristane-induced lupus in mice. Eur J Immunol, 35, pp. 1143-1154.
47. + T cells. J Immunol, 164, pp. 2009-2015.
48. + NK T cells: A novel lymphoid cell lineage with regulatory function. J Allergy Clin Immunol, 98, pp. S263-S269.
49. Taniguchi, M., Seino, K. and Nakayama, T. (2003) The NKT cell system: bridging innate and acquired immunity. Nat Immunol, 4, pp. 1164-1165.
50. Teige, A., Teige, I., Lavasani, S., Bockermann, R., Mondoc, E., Holmdahl, R. and Issazadeh-Navikas, S. (2004) CD1-dependent regulation of chronic central nervous system inflammation in experimental autoimmune encephalomyelitis. J Immunol, 172, pp. 186-194.
51. + T cells play a critical role in costimulation blockade-resistant allograft rejection. J Clin Invest, 104, pp. 1715-1722.
52. Tsunoda, I. and Fujinami, RS (1999) Theiler's murine encephalomyelitis virus. Persistent viral infections, pp. 517-536. John Wiley & Sons, Chichester, West Sussex, England
53. s mouse strains. Brain Pathol, 10, pp. 402-418.
54. Tsunoda, I., Libbey, JE, Kuang, L-Q, Terry, EJ and Fujinami, RS (2005) Massive apoptosis in lymphoid organs in animal models for primary and secondary progressive multiple sclerosis. Am J Pathol, 167, pp. 1631-1646.
55. Tsunoda, I., Tanaka, T., Saijoh, Y. and Fujinami, RS (2007) Targeting inflammatory demyelinating lesions to sites of Wallerian degeneration. Am J Pathol, 171, pp. 1563-1575.
56. Tsunoda, I., Tanaka, T., Terry, EJ and Fujinami, RS (2007) Contrasting roles for axonal degeneration in an autoimmune versus viral model for multiple sclerosis: When can axonal injury be beneficial?. Am J Pathol, 170, pp. 214-226.
57. Tsunoda, I., Wada, Y., Libbey, JE, Cannon, TS, Whitby, FG and Fujinami, RS (2001) Prolonged gray matter disease without demyelination caused by Theiler's murine encephalomyelitis virus with a mutation in VP2 puff B. J Virol, 75, pp. 7494-7505.
58. Tsunoda, I., Tanaka, T. and Fujinami, RS. (2008) Regulatory role of CD1d in neurotropic virus infection. J Virol, 82, pp. 10279-10289.
59. + NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. Clin Immunol, 100, pp. 144-148.
60. Van Kaer, L. (2007) NKT cells: T lymphocytes with innate effector functions. Curr Opin Immunol, 19, pp. 354-364.
61. Yamamura, T., Sakuishi, K., Illes, Z. and Miyake, S. (2007) Understanding the behavior of invariant NKT cells in autoimmune diseases. J Neuroimmunol, 191, pp. 8-15.
62. + T cells that promptly produce interleukin 4. Proc Natl Acad Sci U S A, 92, pp. 11931-11934.